Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Contribution of Melatonin Vs. Placebo in Benzodiazepine Withdrawal in Methadone Maintenance Treatment Patients

NCT00261183 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT00261183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00261183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Contribution of Melatonin Vs. Placebo in Benzodiazepine Withdrawal in Methadone Maintenance Treatment Patients
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2004
Completion date
December 31, 2006
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benzodiazepines